(CSE: SURE) (OTCQB: SURNF), (Profile) through its subsidiary GlucaPharm Inc., is advancing a differentiated next-generation GLP-1 platform centered on GEP-44, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in one of the fastest-growing pharmaceutical markets in history
4A), fibronectin (FN1) (Fig
Recalls & Warnings September 10, 2014 Seller of Joint Pain Supplement Warned for Drug Claims On August 24, 2014, the FDA issued a warning letter to CreAgri, Inc., following a website review, which found statements made about the company's products, including Olivenol plus Easeflex, Olivenol plus Essence Capsules, and Olivenol plus Essence Elixer, to be drug claims
Royea, J
We always recommend informing your prescribing physician about supplemental treatments
Available online at: 45